Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells
about
Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virusProtein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylationCellular cofactors affecting hepatitis C virus infection and replicationInhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virusLiver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cellsNovel type I interferon IL-28A suppresses hepatitis C viral RNA replication.New hepatitis C virus drug discovery strategies and model systemsMurine models of hepatitis C: what can we look forward to?Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay.Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell lineEffect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expressionMolecular virology of hepatitis C virus (HCV): 2006 updateReplication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon ActivitiesReplication of a hepatitis C virus replicon clone in mouse cellsMathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 CellsThe Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host CellsHepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteinsThe C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral ReplicationExpression of hepatitis C virus proteins in epithelial intestinal cells in vivoIdentification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A ProteinCytopathic and Noncytopathic Interferon Responses in Cells Expressing Hepatitis C Virus Subgenomic RepliconsAntiviral effect of interferon lambda against West Nile virusHepatitis C virus replicons: dinosaurs still in business?Focal Distribution of Hepatitis C Virus RNA in Infected LiversHuman occludin is a hepatitis C virus entry factor required for infection of mouse cellsTowards a small animal model for hepatitis CMouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell LineThe HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase functionImmune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFKissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replicationInsertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes.Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.West Nile virus inhibits the signal transduction pathway of alpha interferon.Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines.In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized miceVisualizing hepatitis C virus infection in humanized mice.
P2860
Q21090530-C07C72FE-2E8B-4471-A864-82299C32FADCQ24303935-A380E727-C908-4F1C-A17C-F4FA641083E2Q24317564-46578A7F-4BE8-4D13-AA6D-287F3F0222A9Q24519072-1D6B9D4B-D6CA-49B9-B8C9-7166C05D2509Q24611792-6F8A2757-DE4D-4490-B4E7-F97F283F0BDAQ24658111-17F79A75-E89A-493A-852A-F2AC53BD8A9DQ24658246-57D5B600-E95C-4595-8A3E-28C51A356B17Q24815995-DBE1E88F-9543-46C3-A58B-5F5920B3BE98Q26851159-54893EF7-F100-4121-BCC1-2D911BEA048DQ26991875-21E91049-ABAE-4F1E-B4DA-29235F32C1B2Q27469483-5F7597A7-576A-4C17-BE25-845CFFB0F556Q27472675-B0E68263-8787-40A5-BBCA-84EB6AAAA5A1Q27472822-B6DEED5B-2FA6-4317-9745-2CE77C6CA878Q27473115-931542E2-D436-4BE2-9418-4DD1FB5268BFQ27477459-9D970964-684A-4232-9638-F621F750E5A1Q27477595-6597C973-06FE-4612-B3DB-1666F9A3137AQ27478039-7F0A32C8-6473-436D-9945-A9645039D010Q27478044-D97A6E80-9B72-4C95-8D8B-CC59F51ACD9AQ27478188-0AAA2DA5-70C3-4863-9361-686AEF12186FQ27481029-50F5CA65-A1DE-4A89-A13A-D7F5654881E2Q27482130-603F34B6-8C40-4BCB-BE3C-6C19B0411793Q27485314-CCEC9CC6-45D5-49E0-99C2-5B7B2A59396AQ27485424-0648251C-D140-4E75-97DF-6691578A8332Q27488713-A2B35BE5-29AB-439E-A229-E57905C0C8FFQ27488905-58353646-77EC-4050-91C2-7196E5F7DCDCQ27489107-BE153D74-2813-425C-94C0-1F17C16F3BE9Q27490169-590D850D-EE5F-452B-A71D-ABE696EDB75BQ27490373-DB2DB192-CE1A-4C15-86E0-BD8D435978C1Q27490526-BBCAC5B3-3A79-4EE0-B9FD-76EC8D225A93Q28480396-579DDC92-077C-4E5C-BCD2-F3494BA7AD1BQ29547901-7E733762-DC65-4961-B2BB-03C59396EAD1Q30014846-5D859473-B786-432D-BE43-24A97F7A90C8Q33204253-F49EAF6A-3F16-49EE-AAC1-A37D7A19EE46Q33628805-BD7B24E0-432E-44FC-888F-BE1E96A07D6AQ33718537-B3666300-F38B-4B46-A214-821AD12E1509Q33782525-9B30B349-0F79-4933-9AEA-DDE67D34E7D5Q33892350-D5614E6E-6E3F-4539-B042-8CFE48D4F47EQ34058093-368496EB-4C0D-4EDE-9746-49D047E23032Q34124403-581AAF1F-D697-4856-8DE1-2A19D69DBBF4Q34175159-672094D4-EC91-4259-92CE-8701147D1260
P2860
Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@ast
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@en
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@nl
type
label
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@ast
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@en
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@nl
prefLabel
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@ast
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@en
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@nl
P2093
P2860
P3181
P1433
P1476
Replication of Hepatitis C Vir ...... elial and Mouse Hepatoma Cells
@en
P2093
Christoph Seeger
Ju-Tao Guo
P2860
P304
P3181
P356
10.1128/JVI.77.17.9204-9210.2003
P577
2003-09-01T00:00:00Z